# Median Effective Dose of Dexmedetomidine in Elective Upper Limb Lidocaine Intravenous Regional Anesthesia

> **NCT04304157** · PHASE4 · COMPLETED · sponsor: **South Valley University** · enrollment: 81 (actual)

## Conditions studied

- Intravenous Drug Usage

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT04304157
- **Lead sponsor:** South Valley University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2020-02-29
- **Final completion:** 2020-03-01
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2020-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04304157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04304157, "Median Effective Dose of Dexmedetomidine in Elective Upper Limb Lidocaine Intravenous Regional Anesthesia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04304157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*